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AbstrAct
Background In this UK study, we investigated the 
impact of computerised physician order entry (CPOE) and 
clinical decision support (CDS) implementation on the 
rate of 78 high-risk prescribing errors amenable to CDS.
Methods We conducted a preintervention/
postintervention study in three acute hospitals 
in England. A predefined list of prescribing errors 
was incorporated into an audit tool. At each site, 
approximately 4000 prescriptions were reviewed both 
pre-CPOE and 6 months post-CPOE implementation. The 
number of opportunities for error and the number of 
errors that occurred were collated. Error rates were then 
calculated and compared between periods, as well as by 
the level of CDS.
Results The prescriptions of 1244 patients were audited 
pre-CPOE and 1178 post-CPOE implementation. A total 
of 28 526 prescriptions were reviewed, with 21 138 
opportunities for error identified based on 78 defined 
errors. Across the three sites, for those prescriptions 
where opportunities for error were identified, the 
error rate was found to reduce significantly post-CPOE 
implementation, from 5.0% to 4.0% (P<0.001). CDS 
implementation by error type was found to differ 
significantly between sites, ranging from 0% to 88% 
across clinical contraindication, dose/frequency, drug 
interactions and other error types (P<0.001). Overall, 
43/78 (55%) of the errors had some degree of CDS 
implemented in at least one of the hospitals.
Conclusions Implementation of CPOE with CDS was 
associated with clinically important reductions in the 
rate of high-risk prescribing errors. Given the pre-post 
design, these findings however need to be interpreted 
with caution. The occurrence of errors was found to 
be highly dependent on the level of restriction of CDS 
presented to the prescriber, with the effect that different 
configurations of the same CPOE system can produce 
very different results.
IntroductIon
Computerised physician order entry 
(CPOE) with integrated clinical decision 
support (CDS) software is associated with 
a reduction in medication errors1–4 and 
adverse events.2 5 The impact of CPOE on 
medication errors is strongly influenced 
by the complexity of the system(s) in use 
and the baseline error rate of the study 
site.6–8 Unfortunately, owing to variations 
in the definitions for error and error types, 
as well as the data collection techniques 
adopted by healthcare researchers, direct 
comparison of error rates between sites 
(and settings) is difficult.2 8–11 In those 
studies that do conduct multisite anal-
yses, researchers are required to adopt 
inter-rater reliability testing to assess the 
classification of error types, and often the 
severity.12 This approach can be time-con-
suming, which reduces the feasibility of 
the methodology as a regular and ongoing 
strategy for monitoring error rates.
In 2012, an eDelphi study was conducted 
to identify high-risk prescribing errors for 
the medical inpatient hospital setting that 
were amenable to CDS if prescriptions 
were generated via a CPOE system.13 A 
total of 80 prescribing errors were iden-
tified by 20 experts that could be used to 
standardise the review of prescriptions 
for errors preimplementation and post-
implementation of CPOE in a hospital. 
Targeting the capture of prescription error 
data in a structured and objective manner 
using a clear definition of what constitutes 
an error can help to minimise uncertainty 
over whether or not an error has actually 
occurred.9 14 The approach can provide a 
powerful insight into the incidence and 
prevalence of defined higher risk errors 
that occur across healthcare settings. In 
this case, the data can be used to iden-
tify how factors such as the complexity 
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of systems and the level of CDS may impact on error 
rates, to better inform quality improvement initiatives. 
While it is important to review and monitor for actual 
harms (or adverse events) that occur during the medi-
cation process, such as with retrospective review of 
‘trigger’ events,15 such methods do not identify poten-
tial harms. The use of triggers has also been found to 
identify a lower proportion of adverse events relating 
to prescribing in the UK hospital setting compared 
with prospective review of prescriptions.16
This research aimed to investigate the rate at which 
high-risk prescribing errors occurred preimplemen-
tation and postimplementation of CPOE in hospital 
sites in England, and consider whether the level of 
CDS had an impact on the error rates observed. To 
date, evidence for the impact of CPOE and CDS tech-
nology in the hospital setting has largely been gener-
ated from studies conducted outside the UK, since 
the digital maturity of hospitals in this country is still 
emerging and evolving.17 This study was the first of 
its kind to measure the impact of commercial systems 
in the UK hospital setting using a predefined list of 
high-risk prescribing errors. Considering the pace of 
change relating to digitisation across the National 
Health Service (NHS),18 the findings from this study 
are vital for identifying potential high-risk errors that 
may impact on patient safety, and so inform the safe 
implementation and use of systems across a complex 
system of care.
MAterIAls And Methods
setting
Acute NHS hospitals in England that were planning 
on implementing CPOE were identified as part of a 
National Institute for Health Research programme 
grant: ‘Investigating the adoption, implementation and 
effectiveness of electronic prescribing systems in English 
Hospitals’ (RP-PG-1209-10099). Hospitals were 
eligible for inclusion if (1) they were at least 6 months 
from implementation; and (2) on invitation to partic-
ipate agreed that they had the necessary staff resource 
(ie, a pharmacist or experienced pharmacy technician) 
to capture prescribing data for the defined sample 
size. It was estimated that it would take no more than 
10 min to capture the necessary data for each patient 
reviewed. Four hospitals were identified based on the 
first inclusion criteria relating to their implementa-
tion plans and were invited to participate in the study 
via email, with a follow-up meeting to explain what 
the study would entail and to discuss any approvals 
required from their local research and development 
departments. Sites were informed that their partici-
pation must remain confidential so that participants 
remained blinded to the other sites involved. All four 
hospitals agreed to participate in the study, but only 
three implemented CPOE during the study period of 
the programme grant and so were able to collect both 
preimplementation and postimplementation data.
data collection
Each hospital was given access to the iMPACT (Inves-
tigating Medication Prescribing Accuracy for Critical 
error Types) audit tool to facilitate the capture of data 
relating to the presence of 80 high-risk prescribing 
errors in the general inpatient setting, all of which 
have the potential to be prevented by CDS13 (see 
online supplementary appendix 1). iMPACT is a 
stand-alone Windows application designed to capture 
data on the presence of each of the 80 errors through 
a process of medication chart review and answering a 
series of objective questions relating to the medicines 
a patient is prescribed. For every medicine (including 
regular, when-required and one-off doses), the drug 
was compared against the list of 80 trigger drugs and 
drug classes from the list of errors to see whether 
the prescription could be considered an ‘opportunity 
for error’. Where this was the case, additional ques-
tions were presented to the auditor to assess whether 
an error had occurred (figures 1 and 2). To give an 
example, one of the indicators was ‘Paracetamol 
prescribed at a dose of 4 g over a 24 hours period to 
a patient less than 50 kg’. For this, any orders where 
paracetamol was prescribed would be classified as 
an opportunity for error. Of these, any cases where 
the patient’s weight was less than 50 kg, and the dose 
prescribed to be administered was equal to or greater 
than 4 g in 24 hours, would be classified as an error 
having occurred. Where drugs were included in 
multiple defined errors, for example there were three 
that mentioned gentamicin (see online supplemen-
tary appendix 1), a single order would be classed as 
contributing multiple opportunities for error.
In a pilot study of 100 patients at a paper-based 
hospital, it was estimated that, across all medicines 
prescribed, 5.5% would contain one of the 80 high-risk 
errors. The study was powered to detect a reduction in 
the overall error rate from 5.5% to 4.0% (approxi-
mately a quarter). In order to achieve power of 80% 
(with a two-sided P value of 5%) in each hospital, it 
was calculated that 3156 opportunities for error were 
required preimplementation and postimplementation. 
Assuming an average number of opportunities for 
error of 9.1 per patient (from pilot data), sites were 
informed that this was expected to translate to around 
346 patients (ie, 3156/9.1). Based on an assumption 
of patients having an average of around 10 prescrip-
tions each, the target sample size at each site was 4000 
prescriptions in both the preimplementation and post-
implementation periods.
The CPOE pharmacist at each hospital was trained 
on the use of iMPACT, so that they could train 
the pharmacist or technician allocated to perform 
the data collection for the study. The pharmacist/
technician at each hospital site was asked to visit 
inpatient medical wards and review patients’ medi-
cation charts using iMPACT for a minimum of 4000 
prescription orders on paper and for a further 4000 
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orders 6 months postimplementation of CPOE. Sites 
were asked not to review patients in the surgical, 
paediatric or critical care settings, since the 80 
errors were not identified with these specialties in 
mind. Sites were asked to keep a track of which 
patients had been reviewed to avoid duplication. 
Case selection used a convenience sample approach, 
with sites given flexibility regarding the time that 
reviews were carried out and the patients chosen 
for review. This approach was used to minimise the 
impact of data collection on the organisation (ie, 
with minimal impact in workflow). The only excep-
tion to this was a request not to conduct the review 
when prescribers were likely to be unfamiliar with 
the prescribing processes at the site—specifically in 
August/September when doctors commence training 
or rotate to new posts in the UK. In cases where the 
pharmacist or technician perceived an error to have 
occurred during the audit process, they were asked 
to approach the reporting of the error according to 
local protocol at their hospital. On completion, each 
site exported their data via secure NHS email to the 
University Hospital Birmingham NHS Foundation 
Trust for analysis. Finally, sites were asked to provide 
feedback regarding their use of iMPACT, so that 
any problems with the use of the software could be 
resolved or highlighted to the researchers, or could 
be used to inform interpretation of the data during 
analysis (eg, any difficulties collecting information 
requested by the tool).
decision support
Following data capture post-CPOE, the sites were 
provided with the list of 80 prescribing errors (online 
supplementary appendix 1) and asked to simulate 
these in their CPOE training systems (ie, not for live 
patient admissions). Sites were asked to document 
any CDS that appeared to the prescriber during the 
Figure 1 iMPACT data capture tool: prescribing errors. Drugs and drug classes are categorised for ease of use. iMPACT, Investigating Medication 
Prescribing Accuracy for Critical error Types.
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simulated prescribing process. This was necessary to 
determine the level of CDS existing for each of the 
errors, so that associated CDS and error rates could 
be assessed. After all the data had been received, a 
researcher (SS) analysed the details of the decision 
support for each error at each site and categorised 
these into one of five stages of alerting, according 
to set definitions (table 1). The classifications of 
each instance of CDS were discussed with a second 
researcher (SKP) to validate the coding.
data analysis
For each of the sites, the total numbers of opportuni-
ties for error and the numbers of errors that occurred 
relating to each of the high-risk errors were calculated. 
The error rates were then defined as the number of 
errors that occurred divided by the numbers of oppor-
tunities for error. These rates were compared between 
the pre-CPOE and post-CPOE periods using Fisher’s 
exact tests. Errors were then classified according to 
one of the five levels of CDS that was implemented 
(table 1), which were then further divided for the 
analysis into none, passive or interruptive, and the 
comparisons repeated within each subgroup. Guided 
CDS could be either passive or interruptive, depending 
on the information entered by the prescriber. Since it 
was not possible to record sufficient data to identify 
whether passive or informative guidance was provided 
in each individual case, it was assumed that all guided 
CDS was at the passive level, as this is what would be 
expected to occur in the majority of cases (ie, where 
the prescription was within the guidelines enforced by 
the CDS system).
The approaches to implementation across the three 
sites were then compared. Each error was classified by 
its type and risk rating score. The latter was defined 
as per the original eDelphi study, using the National 
Patient Safety Agency risk matrix19 (online supplemen-
tary appendix 2). The proportion of errors within each 
category of these factors where CDS was applied was 
then compared, using Fisher’s exact test for the error 
type and Kendall’s tau for the risk rating, to account 
for the ordinal nature of this factor. All analyses were 
performed using IBM SPSS V.22, with P<0.05 deemed 
to be indicative of statistical significance throughout.
Figure 2 Capturing drug and drug class data on iMPACT. Clicking on a drug or drug class reveals a series of questions about the prescription and/or the 
patient’s medical and drug history. iMPACT, Investigating Medication Prescribing Accuracy for Critical error Types.
Table 1 Levels of CDS relating to error prevention and the 
associated impact on prescriber workflow
Level of CDS Description
Impact on 
workflow
5 Restricted The prescriber is prevented from 
proceeding with the prescription 
with a hard-stop alert.
Interruptive
4 Permitted An alert appears where a reason 
needs to be given by the prescriber 
to over-ride it in order to progress.
Interruptive
3 Guided Elements of the prescription 
order are auto-populated for the 
prescriber (eg, dose, frequency, 
route).
Interruptive/
passive*
2 Alert An alert appears, but the prescriber 
does not need to over-ride this 
with adding a reason in order to 
progress.
Passive
1 None No CDS appears at the point of 
prescribing.
None
*Passive if the guided decision support is accepted, or interruptive if it 
is over-ridden.
CDS, clinical decision support.
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results
Three out of the four hospitals eligible for inclusion 
in the study completed the data collection pre-CPOE 
and post-CPOE implementation. Two of the hospitals 
(sites 1 and 2) implemented the same CPOE system 
(table 2).
disparities with the data
Two of the 80 errors were identified by the sites as 
problematic during data collection: (1) low molec-
ular weight heparin (LMWH) prescribed without 
the patient’s weight being used to calculate the treat-
ment dose (risk of subtherapeutic or supratherapeutic 
dosing); and (2) LMWH omitted to be prescribed for 
prophylaxis (increased risk of thrombosis). For the 
first of these, feedback from one site identified that 
the CPOE system was designed to minimise the risk 
of the error occurring by mandating that the weight 
was entered as a separate field within the prescription 
and not just in the patient demographics section. If the 
weight had been omitted in the patient’s demographics 
section, it could appear to the data collector that the 
weight had not been used to inform the dosing regimen 
for the LMWH, giving a false rate of error. For the 
second error it was identified that, post-CPOE imple-
mentation, some sites struggled to access assessments 
for venous thromboembolism in order to answer the 
questions presented by the iMPACT tool. In view of 
these findings, these two errors were removed from 
the analysis, leaving 78 errors for consideration.
opportunities for error
The drug charts of 2422 patients were audited across 
the three hospitals—1244 preimplementation and 
1178 postimplementation of CPOE. A total of 28 526 
individual medicine orders were prescribed across both 
periods, with 21 138 opportunities for error identified. 
A summary of the opportunities for error and high-risk 
errors occurring across all sites pre-CPOE and post-
CPOE is provided in online supplementary appendix 
3. Preimplementation, 75/78 (96%) of the defined 
prescribed errors across the three sites had at least one 
opportunity to occur (NOpp), and 70/78 (90%) post-
implementation. Over the study period, 44 had >100 
opportunities for error and 28 had >200. Of the top 
10 found to have the highest opportunity for error, 7 
involved just three drugs: paracetamol (n=2), LMWH 
(n=2) and opioid analgesic (n=3). There were three 
errors where no opportunity for the error occurred 
during the study (namely those relating to ampho-
tericin B, orlistat and nefopam) (online supplementary 
appendix 1).
Across the three sites as a whole, the proportion 
of opportunities for error that resulted in an error 
occurring was found to reduce significantly after the 
introduction of CPOE, from 5.0% to 4.0% (P<0.001) 
(table 3). When analysed on a site level, similar reduc-
tions in error rates were observed after the introduction 
of CPOE at both site 1 (4.3% vs 2.8%, P=0.002) and 
site 3 (7.4% vs 4.4%, P<0.001). However, no signif-
icant change between periods was detected for site 2, 
with error rates of 4.0% vs 4.4% in the pre-CPOE 
versus the post-CPOE periods (P=0.294).
Table 4 summarises the top 10 errors that occurred 
preimplementation and postimplementation of CPOE. 
Seven errors consistently occurred in both processes, 
although with a slightly different rank in overall 
frequency.
In an attempt to explain the lack of improvement 
in error rates observed at site 2, separate exploratory 
subgroup analyses were performed for each of the 78 
errors being considered. This identified two errors 
relating to insulin prescribing that showed consider-
able increases in frequency after CPOE was introduced 
at this site. The first—‘Insulin prescribed to a patient at 
an inappropriate time, allowing for an administration 
without food (except once daily long-acting insulins) 
(Increased risk of hypoglycaemia)’—had an error rate 
that increased from 21.3% (10/47) to 54.2% (32/59) 
Table 3 Summary of the opportunities for an error occurring and high-risk errors that occurred in the three hospitals
Site
Pre-CPOE Post-CPOE
P value
Patient 
records NOpp NErr
Error
rate (%)
Patient 
records NOpp NErr
Error
rate (%)
Relative risk 
(95% CI)
1 365 3867 167 4.3 297 2634 74 2.8 0.65 (0.49 to 0.86) 0.002
2 615 4513 179 4.0 581 4527 200 4.4 1.11 (0.91 to 1.36) 0.294
3 264 2932 216 7.4 300 2665 116 4.4 0.59 (0.47 to 0.74) <0.001
Total 1244 11 312 562 5.0 1178 9826 390 4.0 0.80 (0.70 to 0.91) <0.001
NOpp represents the number of error opportunities generated, while NErr is the number of errors that were found to have occurred. P values are from 
Fisher’s exact tests, with bold values significant at P<0.05.
CPOE, computerised physician order entry.
Table 2 Description of the hospitals that participated in the 
study
Hospital
CPOE 
system
Source of 
system
Ability 
to locally 
configure 
CDS
Interoperability 
with other 
electronic records
Site 1 System A Commercial Yes Yes
Site 2 System A Commercial Yes Yes
Site 3 System B Commercial Yes No
CDS, clinical decision support; CPOE, computerised physician order entry.
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after CPOE implementation, while the second—‘Sol-
uble insulin prescribed to a patient on a when required 
basis (Increased risk of serious episodes of hypogly-
caemia and nocturnal hypoglycaemia post dose)’—saw 
an increase from 2.1% (1/47) to 22.0% (13/59). After 
excluding these, the error rate for the remaining 76 
errors at site 2 was found to show a modest reduction 
post-CPOE implementation from 3.8% (168/4419) to 
3.5% (155/4409).
clinical decision support
A summary of the CDS implemented at each site for 
each of the 78 errors is provided in online supple-
mentary appendix 4. A total of 43/78 (55%) errors 
had some degree of decision support implemented 
(ie, alert to restricted; table 1) in at least one of the 
sites—leaving 45% (35/78) of the errors with no CDS 
at all. The rate of CDS implementation did not differ 
significantly across the three sites (P=0.293), with 
27/78 (35%) of errors triggering some form of CDS 
at sites 2 and 3, and 19/78 (24%) doing so at site 1 
(figure 3). Only three errors had CDS implemented 
at all three sites, namely prescribing amphotericin 
B without stating the brand name and dose, generic 
prescribing of tacrolimus without stating the brand 
and prescribing penicillin-containing compounds to 
patients with penicillin allergy. Despite the overall 
rate of CDS being similar at the three sites, there were 
differences in the manner of implementation (online 
supplementary appendix 5, figure 4). Sites 2 and 3 
used interruptive CDS almost exclusively, with these 
making up 100% (27/27) and 96% (26/27) of CDS, 
respectively. Site 1, on the other hand, had a signifi-
cantly greater usage of passive CDS, with 26% (5/19) 
being at the alert or guidance level.
For those errors with no CDS assigned, a signifi-
cant reduction in the error rate was observed at site 1 
(4.3% vs 3.0%, P=0.023) and site 3 (7.2% vs 3.9%, 
P<0.001) after CPOE implementation, while a signifi-
cant increase in error rate was observed at site 2 (3.3% 
vs 5.0%, P=0.001) (online supplementary appendix 
5). This is likely a result of the insulin errors previously 
Table 4 Top 10 errors occurring pre-CPOE and post-CPOE implementation across all sites
Prescribing error
Pre-CPOE Post-CPOE
Rank NOpp NErr
Error 
rate 
(%) Rank NOpp NErr
Error 
rate 
(%)
Regular opiates prescribed without concurrent use of laxatives (risk of 
severe constipation)
1 486 55 11.3 3 438 37 8.4
Benzodiazepines prescribed long term (ie, more than 2–4 weeks) (risk of 
dependence and withdrawal reactions)
2 129 40 31.0 2 122 38 31.1
Digoxin prescribed concomitantly with a diuretic (risk of hypokalaemia and 
subsequent digoxin toxicity)
3 76 39 51.3 5 59 25 42.4
Insulin prescribed to a patient at an inappropriate time, allowing for 
an administration without food (except once-daily long-acting insulins) 
(increased risk of hypoglycaemia)
4 104 28 26.9 1 113 50 44.2
Citalopram prescribed concomitantly with other QT-prolonging drugs 
(increased risk of arrhythmias)
5 161 28 17.4 8 141 19 13.5
Clopidogrel prescribed to a patient concomitantly with omeprazole or 
esomeprazole (antiplatelet effect of clopidogrel potentially reduced)
6 409 27 6.6 11* 366 14 3.8
Paracetamol prescribed at a dose of 4 g over 24 hours to a patient under 
50 kg (risk of hepatocellular toxicity)
7 841 25 3.0 4 863 29 3.4
Selective serotonin reuptake inhibitor prescribed concomitantly with 
tramadol (increased risk of serotonin syndrome)
8 161 24 14.9 17* 141 5 3.5
Potassium-sparing diuretic (excluding aldosterone antagonists) prescribed 
to a patient also receiving an ACE inhibitor or angiotensin-II receptor 
antagonist (increased risk of severe hyperkalaemia)
9 334 23 6.9 6 272 22 8.1
Statin prescribed concomitantly with a macrolide antibiotic (increased risk 
of myopathy)
10 434 20 4.6 15* 406 6 1.5
More than one paracetamol-containing product prescribed to a patient at a 
time (maximum dose exceeded)
15* 841 14 1.7 7 863 20 2.3
ACE inhibitor or angiotensin-II receptor antagonist prescribed to a 
patient with a potassium level >5.0 mmol/L (can cause or exacerbate 
hyperkalaemia)
11* 334 19 5.7 9 272 19 7.0
Soluble insulin prescribed to a patient on a when-required basis (increased 
risk of serious episodes of hypoglycaemia and nocturnal hypoglycaemia 
post dose)
17* 104 13 12.5 10 113 16 14.2
*Errors ranked outside the top 10 for the stated period, but are included as they were inside the top 10 for the other period.
CPOE, computerised physician order entry; NErr, number of errors; NOpp, number of opportunities for error.
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described, since site 1 adopted a restricted CDS for 
this, while site 2 using the same system had no CDS 
implemented at all.
Passive CDS was used infrequently, not being used 
for any of the 78 errors at site 2. For site 1, no signif-
icant change in error rates was detected for those 
with passive CDS (P=0.673), while the single error 
with passive CDS at site 3 saw a reduction in the 
error rate from 6.0% to 0.0% (P=0.007). Errors with 
interruptive CDS saw significant reductions in error 
rate after CPOE implementation at site 1 (2.9% vs 
0.3%, P<0.001) and site 2 (5.5% vs 3.0%, P=0.002), 
with a near-significant reduction at site 3 (7.8% vs 
5.7%, P=0.056).
In all three sites, the rates of CDS differed signifi-
cantly by the type of error, with implementation rates 
ranging from 0% to 88% across clinical contraindi-
cation, dose/frequency, drug interaction and other 
Figure 3 Implementation of any level of CDS by hospital site. P values are from Fisher’s exact test, and bold P values are significant at P<0.05. CDS, 
clinical decision support.
Figure 4 Implementation of passive and interruptive CDS at the hospital sites. * Passive CDS at Site 3 = 4%. CDS, clinical decision support. 
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error types (all P<0.001; table 5). While sites 2 and 
3 generally targeted similar types of error with CDS, 
the priorities for site 1 were significantly different 
(P<0.001). Of the 25 errors relating to drug interac-
tions, sites 2 and 3 introduced CDS in 21 (84%) and 
22 (88%), respectively, while site 1 only had CDS for 
1 (4%) of these errors. On the other hand, site 1 intro-
duced CDS for 6/29 (21%) of the clinical contraindi-
cation errors, while sites 2 and 3 only had CDS for 1 
(3%) of these. The rate of CDS implementation was 
not found to differ significantly by the risk rating of 
the error at any of the sites (table 5).
dIscussIon
This study is the first of its kind to investigate the 
impact of commercial CPOE systems with integrated 
CDS on the rate of high-risk prescribing errors in the 
UK hospital setting. We analysed over 28 000 prescrip-
tion orders from over 2400 patients for the pres-
ence of 78 defined high-risk prescribing indicators of 
error, preimplementation and postimplementation of 
commercial CPOE systems in three hospital sites. Our 
novel approach to data capture allowed for a direct 
comparison of error rates between sites, and for the 
influence of factors such as the level of CDS to be 
considered in the analysis.
The majority of the 78 errors identified in a previous 
eDelphi study13 had at least one opportunity to occur 
across the three sites, and almost half provided at least 
100 opportunities each. This provides evidence on the 
effectiveness of the method at identifying opportu-
nities for error, and subsequent errors for medicines 
that are likely to be prescribed and are high risk in 
the inpatient general medical setting. The drugs and 
drug classes with the most opportunities for error 
were medicines that are frequently prescribed in UK 
hospitals. Paracetamol is continuously listed as one of 
the top 10 medicines prescribed in the UK community 
setting,20 which increases the likelihood of a prescrip-
tion also being generated for a patient on admission to 
hospital. LMWHs have the potential to be prescribed 
for every patient admitted to the hospital, owing to 
a national guideline recommending that all patients 
are assessed for risk of venous thromboembolism.21 In 
addition to the frequency of prescribing, LMWHs and 
opioid analgesics are listed as classes of medicines most 
associated with death or severe harm outcomes.22
The implementation of CPOE with integrated CDS 
was associated with a significant reduction in the 
rate of high-risk errors amendable to the software. 
However, when analysed on a site level, this was only 
found to be significant in two of the three hospitals 
(sites 1 and 3). Despite using the same system as site 1, 
a significant (and comparable) change in error rate was 
not observed at site 2. This was largely a result of an 
increase in the frequency of errors for which no CDS 
had been put in place by the hospital. The increased 
error rate may be a result of suboptimal or insuffi-
cient training provided to staff postimplementation 
of CPOE and for newer staff inducted at the hospital, 
the provision of which is essential for minimising unin-
tended effects of the technology.23–25 Errors relating 
to the prescribing of insulin in particular were iden-
tified as problematic post-CPOE. This may reflect an 
overdependence on the capability of the system, with 
prescribers having a false expectation that the system 
will alert them to all types of error,26 and as such inad-
vertently generate prescriptions that are inaccurate 
or suboptimal. This overdependence is more likely to 
occur if prescribers assume that the alerts presented in 
Table 5 Summary of error types with any level of clinical decision support across the three sites
Errors (n)
Errors with CDS, n (%)
P value (between-site)Site 1 Site 2 Site 3
Error type <0.001
  Clinical contraindication 29 6 (21) 1 (3) 1 (3)
  Dose/Frequency 13 8 (62) 4 (23) 0 (0)
  Drug interaction 25 1 (4) 21 (84) 22 (88)
  Other† 11 4 (36) 2 (18) 4 (36)
P value (within-site) <0.001 <0.001 <0.001
  Risk rating‡ 0.903
  High risk§ (8–10) 40 7 (18) 13 (33) 12 (30)
  High risk (12) 34 10 (29) 11 (32) 13 (38)
  Extreme risk (15–25) 4 2 (50) 3 (75) 2 (50)
P value (within-site)* 0.113* 0.372* 0.463*
Within-site P values compare the CDS implementation rates across the error types/risk ratings. Between-site P values compare the distribution of CDS 
across the error/risk ratings between the three sites. P values are from Fisher’s exact tests.
*Kendall’s tau and bold P values are significant at P<0.05.
†Other: drug name (n=2); indication (n=1); omission (n=2); route (n=1); and timing/duration (n=6).
‡Risk rating scores are as detailed in online supplementary appendix 2 from the eDelphi study.13
§High-risk rating ranges from 8 to 12, with 12 being the highest risk.
CDS, clinical decision support.
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a system in one hospital are the same as those in the 
same system in another. This reinforces the need for 
users of systems to be made aware during their training 
that systems may be configured very differently. It may 
also emphasise the importance of standardisation of 
configuration between the same systems for errors that 
are considered high risk.
The rate of CDS implementation was similar at each 
of the three sites, ranging from approximately a quarter 
to a third of the errors having some CDS configured. 
However, there were differences in the manner of 
implementation, even between those sites using the 
same system (sites 1 and 2 using system A). First, the 
types of errors targeted with CDS differed, with two of 
the hospitals (sites 2 and 3) choosing to focus most of 
their CDS on ‘Drug interaction’ errors, while the third 
hospital (site 1) focused more on ‘Clinical contrain-
dication’ and ‘Dose/Frequency’ errors. Second, when 
hospitals did choose to implement CDS, the level of 
alerting implemented was significantly different, with 
two sites (sites 2 and 3) almost exclusively applying 
interruptive CDS and one opting to apply more 
passive alerts (site 1). These findings suggest that 
the decision-making process for local configuration 
is not entirely influenced by the technological capa-
bility of the system in use, and that other factors are 
likely to be at play. Site 1 had CDS implemented for 
the smallest number of errors and also had the lowest 
rate of interruptive CDS. This may have been due to 
a decision to take a more cautious approach to the 
implementation—mindful of the potential for ‘alert 
fatigue’, which may negate the beneficial effects of the 
software.27–30 In contrast, the two sites with the most 
CDS took a very different approach, and almost exclu-
sively implemented alerts that were interruptive for 
the prescriber. This may highlight an organisational 
concern regarding liability should an error occur that 
the system had the functionality to reduce the risk of, 
or prevent entirely.27 Alternatively there may be a lack 
of knowledge relating to the unintended consequences 
of such configuration among the implementation team. 
Hospitals may also have been targeting errors that they 
felt were most likely to occur in their setting or have 
previously been known to cause harm (eg, based on 
local incident reports). Finally, with the rapid increase 
in the use of CPOE worldwide,31 32 there are a multi-
tude of quantitative and qualitative studies regarding 
implementation. Since implementation in the UK is 
relatively new, it may also be the case that some hospi-
tals are reviewing the literature to inform their strategy 
for configuration. For example, a US study by Phan-
salkar et al33 lists 15 high-priority drug–drug interac-
tions that should have CDS implemented, which may 
explain why some hospitals chose to implement more 
drug interaction alerts over any other error type. Six of 
the 15 alerts in this study were considered high risk in 
the UK, as identified through our eDelphi study.13 Two 
sites in this study had interruptive CDS implemented 
for all six of these drug interactions, and one site had 
none implemented at all. Further research would be 
beneficial to determine the sociotechnical factors that 
may influence the strategies adopted by hospitals to 
inform the process of CDS implementation.
The ability to locally configure CPOE systems is an 
important factor for the successful implementation 
of the technology in an organisation.24 34 However, 
local configuration demands both time and expertise. 
The variation in practice observed may highlight a 
lack of national guidance in relation to implementa-
tion strategies, previously highlighted as a problem in 
a UK-based study of hospitals in England.30 34 It may 
also highlight a lack of knowledge as a result of little 
or no informatics training and limited experience 
with the technology.35 In the UK, it costs between 
£0.5 and £3 million to implement CPOE, depending 
on the digital maturity of the hospital, existing infor-
mation technology infrastructure and staff resource.17 
Given the financial investments and the potential for 
unintended consequences when new technologies are 
introduced, it is important to assess whether organ-
isations are using systems optimally to improve the 
quality of prescribing to benefit patient care.36 A more 
consistent approach for errors perceived as high risk 
(critical) could prove beneficial for healthcare organ-
isations such as the NHS. Designing CDS to inter-
rupt the prescriber for critical errors has certainly 
been recommended as a strategy for improving the 
utilisation of the software.37 This is supported by the 
findings from this study that showed the presence of 
interruptive CDS that had the biggest impact on the 
rate of error.
Since the design of inpatient drug charts has been 
suggested as a primary cause of medication errors 
in UK hospitals,9 adopting a standard for high-risk 
errors has the potential to improve clinical outcomes 
by reducing variations in prescribing practice,38 which 
may be particularly beneficial in healthcare systems 
where staff move between hospitals as part of their 
training. The findings from this study demonstrate a 
significant opportunity for system optimisation and 
the adoption of a more consistent approach to this. 
Given the risk rating of the errors, this could result in 
real improvements in prescribing safety.
strengths and limitations
The eDelphi that formed the basis of the data capture 
was conducted in 2012 and was based on the UK 
hospital setting. As new therapeutic agents are intro-
duced and older ones go out of favour, the likelihood 
scores for their occurrence in clinical practice may 
well adjust, possibly to the point that they would no 
longer qualify for inclusion in the list of high-risk 
errors, according to our methodology. As evidence 
of this, when the eDelphi was repeated in 2015, 126 
indicators of error were identified by 35 experts, 80 
of which were from the original eDelphi and 46 were 
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new.39 Errors involving direct oral anticoagulants were 
included for the first time, reflective of the change in 
practice for prescribing these drugs. This demonstrates 
the importance of ongoing review of CDS and opti-
misation to ensure systems reflect current practice. 
iMPACT has now been designed as a web-based tool 
for NHS hospitals to capture data on prescribing error 
rates specific to these revised 126 indicators.39 Since 
the eDelphi and this study were conducted in the UK, 
the findings may not be transferable to hospitals in 
other countries.
This multisite study was conducted in three hospitals 
in England. A strength of this study is the number of 
prescriptions reviewed preimplementation and post-
implementation of CPOE. Data collection was entirely 
dependent on when hospitals were due to go live, and 
as such the study was staggered over a period of 18 
months. However, this was not believed to impact on 
the data captured, since sites were not aware of the 
other hospitals participating in the study and so could 
not discuss the process or findings. The research team 
did not influence the decision-making at each hospital 
regarding the levels of CDS, which was important for 
gaining a true representation of a ‘real-world’ CPOE 
implementation. To our knowledge, there were no 
other major transformations in the delivery of the 
service to facilitate the medication process at any of 
the hospitals during the study period. As such, the 
introduction of CPOE is most likely responsible for 
the outcomes observed.
The iMPACT tool facilitated a standardised approach 
to data collection, allowing for a direct comparison 
of error rates. The tool was tested for usability and 
interpretation by a pharmacist who was independent 
from the research group. However, the tool was not 
assessed for its sensitivity or specificity in identifying 
opportunities for error and errors that had occurred.
A convenience sampling approach was used to select 
patients for inclusion in the study. As a result, the 
selection of patients may not be fully representative of 
the overall general medicine inpatient population in a 
setting. Ideally, it would have been preferable to stan-
dardise patient selection across the sites based on the 
day of the week and time of day, and by randomising 
the patients selected for inclusion. However, this was 
not logistically possible in this study, owing to the 
variation in the time of CPOE implementation across 
sites. Nevertheless, this approach could be used in the 
future when sites have all achieved maturity. In order 
to obtain a snapshot of prescribing that was reflective 
of the majority of the year, sites were asked to avoid 
conducting the review when prescribers were more 
likely to be unfamiliar with the paper or electronic 
prescribing processes. Information relating to the ward 
and prescriber was not recorded on iMPACT. This 
ensured that any patient data collected (ie, age) would 
remain non-identifiable and adhered to the informa-
tion governance processes at each hospital site. In view 
of this, it was not possible to account for the impact of 
clustering by these factors in the analysis.
CPOE and CDS have been associated with new error 
types,40 and this has been shown to be the case at two 
of the study sites that participated in this research.29 
Identifying these errors is important in the ongoing 
monitoring and optimisation of systems to minimise 
the risks of the technology to patient safety. However, 
in view of our approach to capture data on the occur-
rence of defined high-risk prescribing errors, inves-
tigating the specifics of any new errors was outside 
the scope of the study. This would require analysis of 
all prescription data generated, along with case note 
review, as well as the monitoring of local patient safety 
incident reports. This approach could be adopted 
alongside the use of iMPACT in future preimplemen-
tation/postimplementation studies to provide a more 
comprehensive overview of the impact of the tech-
nology on error.
conclusIons
Our novel approach to standardise the capture of 
defined prescribing errors has enabled error rates to 
be directly compared between study sites. Findings 
should however be interpreted with caution given the 
pre-post design. Implementation of CPOE with inte-
grated CDS was associated with significant reductions 
in the rate of high-risk prescribing errors overall, with 
these overall findings having been driven by two of 
the sites. The implementation of CDS was found to 
vary significantly between the hospitals investigated, 
both in relation to the error type targeted and the 
level of alert presented to the prescriber. Sites with the 
same system in use generated very different results, 
indicating that outcomes are influenced by system 
capability and crucially by the manner of implemen-
tation, including the decision-making process during 
local configuration. This emphasises the importance 
of considering sociotechnical factors when imple-
menting CPOE/CDS technology. Our methodological 
approach should help organisations to identify signif-
icant opportunities for system optimisation, and our 
findings can be used to guide optimal configuration of 
CDS for high-risk errors amendable to such software, 
in order to promote consistent practice and to benefit 
patient care.
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